Press Release: Sanofi announces end of program evaluating tusamitamab ravtansine after a 2L NSCLC Phase 3 trial did not meet a primary endpoint
Sanofi is discontinuing the global clinical development program of tusamitamab ravtansine.
Uncategorized
Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced the appointment of Phillip Hains as the Company’s new Chief Financial Officer, effective 31 January 2024.
Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer Read More »
Sensorion Publishes Results of Combined General Meeting Resolutions – December 21, 2023
Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the results of resolutions presented at its Combined General Meeting, held on December 20, 2023 and made them available on the dedicated section of its website.
Sensorion Publishes Results of Combined General Meeting Resolutions – December 21, 2023 Read More »
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
Moleculin Biotech, Inc. announced that it has entered into a securities purchase agreement with a single healthcare-focused institutional investor and certain of the Company’s executive officers and directors to purchase 7,044,836 shares of common stock in a registered direct offering priced at-the-market under Nasdaq rules.
A World War II-Era Company Reshapes Itself as a Biotech Powerhouse
Now designated as a Tech Hub by the White House, Alabama’s nonprofit Southern Research is winnowing its focus and investing in healthcare solutions.
A World War II-Era Company Reshapes Itself as a Biotech Powerhouse Read More »
Shared Savings Program linked to net losses in traditional Medicare, study finds
However, the program was linked to savings in Medicare Advantage and for the CMS overall.
Shared Savings Program linked to net losses in traditional Medicare, study finds Read More »
FDA approves first DNA test for risk of opioid use disorder
The approval comes a little over one year after an FDA advisory committee overwhelmingly voted against an earlier version of the test.
FDA approves first DNA test for risk of opioid use disorder Read More »
Jefferson Health and Lehigh Valley Health Network announce intent to merge
The deal would create a 30-hospital health system serving Pennsylvania and New Jersey.
Jefferson Health and Lehigh Valley Health Network announce intent to merge Read More »
Apple to pause US sales of smartwatches with pulse oximetry
The tech giant’s move follows a USITC ruling that found the watches infringed some of Masimo’s patents for measuring blood oxygen.
Apple to pause US sales of smartwatches with pulse oximetry Read More »
Steward Health Care hit with False Claims Act lawsuit
The suit alleges a Steward-run hospital improperly billed Medicare for more than 1,000 false claims.
Steward Health Care hit with False Claims Act lawsuit Read More »